Allianz Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.6M | Sell |
47,028
-634
| -1% | -$191K | 0.01% | 832 |
|
|
2026
Q1 | $15.8M | Sell |
47,662
-213
| -0.4% | -$72.5K | 0.02% | 694 |
|
|
2025
Q4 | $19M | Sell |
47,875
-58,941
| -55% | -$26.1M | 0.02% | 622 |
|
|
2025
Q3 | $48.7M | Sell |
106,816
-99,177
| -48% | -$40.4M | 0.05% | 342 |
|
|
2025
Q2 | $67.2M | Sell |
205,993
-12,510
| -6% | -$3.46M | 0.08% | 238 |
|
|
2025
Q1 | $59M | Buy |
218,503
+109,632
| +101% | +$28.2M | 0.08% | 261 |
|
|
2024
Q4 | $25.6M | Buy |
108,871
+82,065
| +306% | +$21.6M | 0.03% | 478 |
|
|
2024
Q3 | $7.37M | Buy |
26,806
+8,632
| +47% | +$2.25M | 0.01% | 861 |
|
|
2024
Q2 | $4.42M | Buy |
18,174
+6,660
| +58% | +$1.05M | 0.01% | 1025 |
|
|
2024
Q1 | $1.72M | Sell |
11,514
-2,275
| -16% | -$380K | ﹤0.01% | 1235 |
|
|
2023
Q4 | $2.64M | Sell |
13,789
-662
| -5% | -$113K | ﹤0.01% | 1209 |
|
|
2023
Q3 | $2.56M | Sell |
14,451
-2,144
| -13% | -$409K | ﹤0.01% | 1320 |
|
|
2023
Q2 | $3.15M | Sell |
16,595
-2,052
| -11% | -$407K | 0.01% | 1075 |
|
|
2023
Q1 | $3.74M | Buy |
18,647
+294
| +2% | +$61.8K | 0.01% | 1091 |
|
|
2022
Q4 | $4.36M | Sell |
18,353
-3,390
| -16% | -$723K | 0.01% | 977 |
|
|
2022
Q3 | $4.35M | Sell |
21,743
-27,968
| -56% | -$5.33M | 0.01% | 940 |
|
|
2022
Q2 | $7.25M | Buy |
49,711
+4,783
| +11% | +$679K | 0.01% | 989 |
|
|
2022
Q1 | $7.34M | Sell |
44,928
-6,136
| -12% | -$935K | 0.01% | 1085 |
|
|
2021
Q4 | $8.67M | Sell |
51,064
-4,490
| -8% | -$835K | 0.01% | 1043 |
|
|
2021
Q3 | $10.5M | Buy |
55,554
+20,955
| +61% | +$3.93M | 0.01% | 999 |
|
|
2021
Q2 | $5.87M | Sell |
34,599
-2,860
| -8% | -$419K | ﹤0.01% | 1050 |
|
|
2021
Q1 | $5.29M | Buy |
37,459
+7,445
| +25% | +$1.12M | 0.01% | 1043 |
|
|
2020
Q4 | $3.9M | Sell |
30,014
-1,595
| -5% | -$213K | ﹤0.01% | 1127 |
|
|
2020
Q3 | $4.6M | Sell |
31,609
-7,002
| -18% | -$995K | 0.01% | 1003 |
|
|
2020
Q2 | $5.72M | Sell |
38,611
-5,214
| -12% | -$703K | 0.01% | 1149 |
|
|
2020
Q1 | $4.77M | Sell |
43,825
-14,881
| -25% | -$1.72M | 0.01% | 1177 |
|
|
2019
Q4 | $6.76M | Sell |
58,706
-29,211
| -33% | -$2.91M | 0.01% | 1344 |
|
|
2019
Q3 | $7.09M | Sell |
87,917
-16,736
| -16% | -$1.32M | 0.01% | 1284 |
|
|
2019
Q2 | $7.59M | Sell |
104,653
-19,274
| -16% | -$1.48M | 0.01% | 1313 |
|
|
2019
Q1 | $11.6M | Sell |
123,927
-23,886
| -16% | -$2M | 0.01% | 1076 |
|
|
2018
Q4 | $10.7M | Sell |
147,813
-26,637
| -15% | -$2.05M | 0.01% | 1079 |
|
|
2018
Q3 | $15.3M | Buy |
174,450
+38,720
| +29% | +$3.89M | 0.01% | 1054 |
|
|
2018
Q2 | $13.4M | Buy |
135,730
+63,975
| +89% | +$6.35M | 0.01% | 1118 |
|
|
2018
Q1 | $8.55M | Buy |
71,755
+100
| +0.1% | +$12.9K | 0.01% | 1318 |
|
|
2017
Q4 | $9.1M | Buy |
71,655
+44,655
| +165% | +$5.61M | 0.01% | 1363 |
|
|
2017
Q3 | $3.17M | Sell |
27,000
-3,177
| -11% | -$271K | ﹤0.01% | 1839 |
|
|
2017
Q2 | $2.38M | Buy |
30,177
+3,177
| +12% | +$203K | ﹤0.01% | 1917 |
|
|
2017
Q1 | $1.38M | Hold |
27,000
| – | – | ﹤0.01% | 2130 |
|
|
2016
Q4 | $1.01M | Sell |
27,000
-63,574
| -70% | -$2.66M | ﹤0.01% | 2208 |
|
|
2016
Q3 | $6.3M | Sell |
90,574
-2,049
| -2% | -$145K | 0.01% | 1528 |
|
|
2016
Q2 | $5.14M | Buy |
92,623
+41,020
| +79% | +$2.58M | 0.01% | 1502 |
|
|
2016
Q1 | $3.24M | Buy |
51,603
+673
| +1% | +$44.7K | ﹤0.01% | 1605 |
|
|
2015
Q4 | $4.81M | Hold |
50,930
| – | – | 0.01% | 1369 |
|
|
2015
Q3 | $4.09M | Sell |
50,930
-1,500
| -3% | -$167K | ﹤0.01% | 1346 |
|
|
2015
Q2 | $6.29M | Sell |
52,430
-50,880
| -49% | -$6.08M | 0.01% | 1299 |
|
|
2015
Q1 | $10.8M | Buy |
103,310
+23,000
| +29% | +$2.33M | 0.01% | 928 |
|
|
2014
Q4 | $7.79M | Buy |
80,310
+27,860
| +53% | +$2.58M | 0.01% | 1053 |
|
|
2014
Q3 | $4.1M | Sell |
52,450
-2,000
| -4% | -$129K | ﹤0.01% | 1157 |
|
|
2014
Q2 | $3.44M | Buy |
54,450
+455
| +0.8% | +$27K | ﹤0.01% | 1034 |
|
|
2014
Q1 | $3.63M | Sell |
53,995
-22,000
| -29% | -$1.7M | ﹤0.01% | 1030 |
|
|
2013
Q4 | $4.89M | Sell |
75,995
-79,595
| -51% | -$4.75M | 0.01% | 953 |
|
|
2013
Q3 | $9.96M | Buy |
155,590
+17,000
| +12% | +$847K | 0.01% | 671 |
|
|
2013
Q2 | $4.3M | Buy |
+138,590
| New | +$3.69M | 0.01% | 941 |
|
Other funds holding ALNY
Allianz Asset Management's ALNY Position: Q2 2026 in Review
Allianz Asset Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 1.3% in Q2 2026, selling an estimated $191K and leaving 47,028 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #832.
Allianz Asset Management first reported a position in ALNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.2M in Q2 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Allianz Asset Management held 47,028 shares of Alnylam Pharmaceuticals worth $15.6M as of Q2 2026.
- Allianz Asset Management sold 634 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $191K.
- Alnylam Pharmaceuticals made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #832 holding.
- Allianz Asset Management first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Allianz Asset Management's Alnylam Pharmaceuticals position peaked at $67.2M in Q2 2025.
- 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.